SEC 13F Intelligence

Dsc Advisors, L.P. / VYNE

Dsc Advisors, L.P.’s Vyne Therapeutics Inc Position

Does Dsc Advisors, L.P. own Vyne Therapeutics Inc (VYNE)? Yes — 696.5K shares worth $1M (+11.93% of its 13F portfolio) as of Q3 2024.

Position Value
$1M
Q3 2024
Shares
696.5K
% of Portfolio
+11.93%
Quarters Held
7
currently held

Position History VYNE

Reported value by quarter
Q1 ’23: $354,200Q1 ’23Q2 ’23: $466,900Q2 ’23Q3 ’23: $460,000Q3 ’23Q4 ’23: $2MQ4 ’23Q1 ’24: $2MQ1 ’24Q2 ’24: $1MQ2 ’24Q3 ’24: $1MQ3 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2024696.5K$1M+11.93%
Q2 2024696.5K$1M+4.58%
Q1 2024696.5K$2M+3.42%
Q4 2023696.5K$2M+2.68%
Q3 2023115.0K$460,000+0.59%
Q2 2023115.0K$466,900+0.70%
Q1 2023115.0K$354,200+0.31%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dsc Advisors, L.P.’s full portfolio or all institutional holders of VYNE.